Pramono said Jakarta is ready to follow the central government over the TB vaccine test

Jakarta -Gates foundation plans to make Indonesia a TB vaccine testing that has been developed by Bill Gates. The Governor of DKI Jakarta, Pramono Anung, also said he is ready to follow the direction of the central government if Jakarta is appointed as one of the vaccine test locations. “It is the authority of the central government (to appoint a hearing place),” he said at Jicc, Central Jakarta, on Saturday (5/17/2025). “Yes, it is on the central government, if the central government sets Jakarta as one of the vaccines, we will just join,” he continued. Browse to continue with the previous content, Bio Farma Shadiq Akasya President Director spoke about the most likely Tuberculosis vaccination (TBC) M72 whose development was funded by Bill Gates is produced in Indonesia. By reflecting on the collaboration previously conducted since 2014, the same approach is performed by Bio Farma. “We were indeed in collaboration with the Gates Foundation for the development of polio vaccines from 2014, from where we produce polio for world purposes, not just for Indonesia,” he explained on Thursday (5/15) at a press conference at the office of the Food and Drug Supervisory Agency (BPOM), Central -Jakarta. “Now there is a new vaccine that is also supported by the Gates Foundation, in Indonesia we have performed clinical trials, and of course we hope to support the production of Biofarma. Although there is no written commitment agreement, we continue to approach,” he explained. The TB vaccine M72 was given to at least 2 thousand participants. The first time it has been tested for clinically in Europe, it has so far entered the clinical test phase 3. The 2 thousand participants are still monitored to ensure how much the effectiveness of the vaccine in protecting a person against TB exposure or the possibility of severe symptoms. Of the 15 global TB vaccine candidates, M72 is the most progressive in its development. Bio Farma ensured that the relationship with the Gates Foundation went well. “This TB vaccine is most expected and the research has been working for over 30 years, we must appreciate because the development is relatively faster and advanced than other vaccine candidates,” he concluded. (Call/Zap) HOEGENG Awards 2025 Read the inspirational story of the exemplary police candidate here